The firm’s 50-day moving average price is $50.28 … PEG Ratios above 1 indicate that a company could be overvalued. A PEG ratio is a valuation analysis that compares the price earnings ratio (PE) to the EPS growth rate of a company. AstraZeneca's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.039. The stock has a 50-day moving average of $50.78 and a 200 day moving average of $52.50. AstraZeneca has a … AstraZeneca PLC has a twelve month low of $36.15 and a twelve month high of $64.94. The price/earnings-to-growth ratio, or the PEG ratio, is a metric that helps investors value a stock by taking into account a company’s market … The business has a 50 day simple moving average of $50.41 and a two-hundred day simple moving average of $51.98. The company has a debt-to-equity ratio of 1.34, a quick ratio of 0.76 and a current ratio of 0.96. The trailing PE ratio is 53.56 and the forward PE ratio is 20.24. The first major growth driver for AstraZeneca is the company's oncology portfolio . Valuation Ratios. The stock has a market cap of $135.67 billion, a price-to-earnings ratio of 53.84, a PEG ratio of 1.18 and a beta of 0.55. The business has a 50 day simple moving average of $50.93 and a 200 day simple moving average of $52.33. AstraZeneca's PEG ratio is 1.14. The technical evaluation for the stock shows the PEG ratio is 2.05, with AZN’s current price about -2.12% and -4.09% off the 20-day and 50-day simple moving averages respectively. AstraZeneca's PEG ratio. Price to Earnings Growth Ratio. The P/E ratio of AstraZeneca is 50.70, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 39.52. The firm has a market capitalization of $127.08 billion, a PE ratio of 50.44, a PEG ratio of 1.18 and a beta of 0.55. Price to Earnings Ratio vs. Sector. AZN's PEG comes from its forward price to earnings ratio being divided by its growth rate. After two decades of going sideways, AstraZeneca has two big catalysts in its sails and a PEG ratio just above 1. This is one of the best ways to identify relative value, especially in companies that are growing faster than the general market and whose price earnings multiples seemed quite high when compared to other stocks. A low ratio … A PEG ratio of 1 represents a perfect correlation between earnings growth and share price. The stock has a market capitalization of $130.73 billion, a P/E ratio of 51.89, a PEG ratio of 1.18 and a beta of 0.55. AstraZeneca has a PEG Ratio of 1.18. The Relative Strength Index (RSI, 14) currently prints 43.24, while 7-day volatility ratio is 1.6% and 1.75% in … Find out all the key statistics for Astrazeneca PLC (AZN), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. The company has a market capitalization of $131.23 billion, a price-to-earnings ratio of 52.08, a PEG ratio of 1.18 and a beta of 0.55. AstraZeneca has a 12 month low of $36.15 and a 12 month high of $64.94.
Deutsche Basketball Nationalmannschaft Olympia, Ikea Turnmatte Rosa, Großfurtner Schlachthof Corona, Schlachten 12 Jahrhundert, Lilly Diabetes Broschüre, Tim Weiss Author, Tierwohl Label Hähnchen, Backpapier Als Knisterfolie,